lepromatous

There is a difference in immune response to the tuberculoid and lepromatous forms.

Pink and red discolorations are also associated in patients with lepromatous leprosy.

Lepromatous leprosy is a skin condition consisting of pale macules.

Three-drug therapy can cure even the worst cases of lepromatous leprosy."

Oral zinc as an adjunct to dapsone in lepromatous leprosy.

The treatment of lepra reaction in lepromatous leprosy.

Dimorphous leprosy creates skin lesions characteristic of the lepromatous and tuberculoid forms.

The Mitsuda lepromin reaction in long-term treated lepromatous leprosy.

Borderline lepromatous leprosy is a skin condition with numerous, symmetrical skin lesions.

It was effective to some degree in neuralgic pain, but not effective in lepromatous leprosy.

EN may also be due to excessive antibody production in lepromatous leprosy leading to deposition of immune complexes.

Patients with "lepromatous" (Virchowian) HD have no skin reaction to the antigen.

Lepromatous cases show large numbers of organisms deep in the dermis, but whether they reach the skin surface in sufficient numbers is doubtful.

The intermediate subtypes are borderline tuberculoid, midborderline, and borderline lepromatous leprosy.

M. lepromatosis is a relatively newly identified mycobacterium isolated from a fatal case of diffuse lepromatous leprosy in 2008.

Pedley reported that the majority of lepromatous patients showed leprosy bacilli in their nasal secretions as collected through blowing the nose.

It is seen in multiple conditions and has been classically described for Lepromatous leprosy as well as Paget's disease of bone.

In its conclusions, they clearly wrote that sulfanilamide cannot be regarded as a curative agent for leprous lesions, either of the macular or lepromatous type.

There is even a "Latapi Lepromatosis" which is a form of diffuse nonnodular lepromatous leprosy.

Davey and Rees indicated that nasal secretions from lepromatous patients could yield as much as 10 million viable organisms per day.

Histologic study of the Mitsuda reaction in patients with lepromatous leprosy and its prognostic value in bacteriologically negative cases.

Treatment of tuberculoid leprosy is continued for at least 1 to 2 years, while patients with lepromatous leprosy are generally treated for 5 years.

Lepromatous leprosy symptoms are a chronically stuffy nose and many skin lesions and nodules on the front and back of the body.

The Multibacillary classification includes midborderline, borderline lepromatous and lepromatous leprosy.

This reaction occurs within 48 hours of injection of lepromin and is seen in both lepromatous and tuberculoid forms of leprosy.